JP2016520289A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016520289A5 JP2016520289A5 JP2016502049A JP2016502049A JP2016520289A5 JP 2016520289 A5 JP2016520289 A5 JP 2016520289A5 JP 2016502049 A JP2016502049 A JP 2016502049A JP 2016502049 A JP2016502049 A JP 2016502049A JP 2016520289 A5 JP2016520289 A5 JP 2016520289A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- sequence
- polynucleotide
- level
- agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361794788P | 2013-03-15 | 2013-03-15 | |
| US61/794,788 | 2013-03-15 | ||
| PCT/US2014/026094 WO2014151606A2 (en) | 2013-03-15 | 2014-03-13 | Methods of treating pancreatic cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016520289A JP2016520289A (ja) | 2016-07-14 |
| JP2016520289A5 true JP2016520289A5 (https=) | 2017-04-13 |
Family
ID=51581651
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016502049A Withdrawn JP2016520289A (ja) | 2013-03-15 | 2014-03-13 | 膵臓癌の治療方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20160030561A1 (https=) |
| EP (1) | EP2971146A4 (https=) |
| JP (1) | JP2016520289A (https=) |
| KR (1) | KR20150130466A (https=) |
| CN (1) | CN105051215A (https=) |
| AU (1) | AU2014233736A1 (https=) |
| CA (1) | CA2900969A1 (https=) |
| HK (1) | HK1211322A1 (https=) |
| IL (1) | IL240688A0 (https=) |
| MX (1) | MX2015011386A (https=) |
| WO (1) | WO2014151606A2 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2413087T3 (es) | 2006-06-13 | 2013-07-15 | Oncomed Pharmaceuticals, Inc. | Composiciones y métodos para el diagnóstico y tratamiento del cáncer |
| WO2008091641A2 (en) | 2007-01-24 | 2008-07-31 | Oncomed Pharmaceuticals, Inc. | Compositions and methods for diagnosing and treating cancer |
| CN102112490B (zh) | 2008-07-08 | 2014-10-22 | 昂考梅德药品有限公司 | Notch1受体结合剂和其使用方法 |
| US9132189B2 (en) | 2008-07-08 | 2015-09-15 | Oncomed Pharmaceuticals, Inc. | Notch1 binding agents and methods of use thereof |
| EP2970468B1 (en) | 2013-03-13 | 2021-07-07 | Novartis AG | Notch2 binding molecules for treating respiratory diseases |
| EP3455631B1 (en) * | 2016-05-09 | 2020-06-24 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for classifying patients with a solid cancer |
| EP3595717A1 (en) * | 2017-03-17 | 2020-01-22 | Imclone, LLC | Combination therapy for pancreatic cancer |
| KR20200005540A (ko) * | 2017-04-14 | 2020-01-15 | 제넨테크, 인크. | 암의 진단 및 치료 방법 |
| WO2019203255A1 (ja) * | 2018-04-19 | 2019-10-24 | 公立大学法人横浜市立大学 | 再構成癌組織を用いた薬剤評価方法 |
| EP4526350A4 (en) * | 2022-05-20 | 2025-10-22 | Mayo Found Medical Education & Res | TREATMENT OF CHEMORESISTANT CANCERS WITH NOTCH3 INHIBITORS |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040102390A1 (en) * | 2002-11-21 | 2004-05-27 | Isis Pharmaceuticals Inc. | Modulation of Notch3 expression |
| WO2005111072A2 (en) * | 2004-04-29 | 2005-11-24 | The Trustees Of Columbia University In The City Of New York | Notch-based fusion proteins and uses thereof |
| US7807630B2 (en) * | 2007-09-14 | 2010-10-05 | Vanderbilt University | Targeting of Notch3 receptor function for cancer therapy |
| CN102112490B (zh) * | 2008-07-08 | 2014-10-22 | 昂考梅德药品有限公司 | Notch1受体结合剂和其使用方法 |
| EP2389390B1 (en) * | 2009-01-26 | 2020-11-04 | Academisch Ziekenhuis Leiden h.o.d.n. LUMC | Means and methods for modulating notch3 protein expression and/or the coding region of notch3; compositions and use thereof in the treatment of cadasil |
| MX342250B (es) * | 2009-09-30 | 2016-09-22 | Genentech Inc | Tratamiento de cánceres resistentes a antagonistas notch1, mediante el uso de antagonistas notch3. |
-
2014
- 2014-03-13 WO PCT/US2014/026094 patent/WO2014151606A2/en not_active Ceased
- 2014-03-13 CA CA2900969A patent/CA2900969A1/en not_active Abandoned
- 2014-03-13 US US14/776,259 patent/US20160030561A1/en not_active Abandoned
- 2014-03-13 JP JP2016502049A patent/JP2016520289A/ja not_active Withdrawn
- 2014-03-13 HK HK15112123.8A patent/HK1211322A1/xx unknown
- 2014-03-13 CN CN201480016155.2A patent/CN105051215A/zh active Pending
- 2014-03-13 AU AU2014233736A patent/AU2014233736A1/en not_active Abandoned
- 2014-03-13 KR KR1020157028505A patent/KR20150130466A/ko not_active Withdrawn
- 2014-03-13 MX MX2015011386A patent/MX2015011386A/es unknown
- 2014-03-13 EP EP14768242.1A patent/EP2971146A4/en not_active Withdrawn
-
2015
- 2015-08-20 IL IL240688A patent/IL240688A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016520289A5 (https=) | ||
| Jain et al. | Mantle cell lymphoma in 2022—A comprehensive update on molecular pathogenesis, risk stratification, clinical approach, and current and novel treatments | |
| Allanore et al. | Systemic sclerosis | |
| JP2017501137A5 (https=) | ||
| WO2014151606A4 (en) | Methods of treating pancreatic cancer | |
| JP2022125079A (ja) | がん転移の予後診断および処置のための方法 | |
| ES2529593T3 (es) | Marcadores de enfermedades y usos de los mismos | |
| ES2613055T3 (es) | Diagnóstico de interferón de tipo 1 | |
| JP2020062012A (ja) | 神経膠芽腫を治療するための診断方法及び組成物 | |
| CN105980576B (zh) | 用于源自乳腺癌的骨转移癌的预后和治疗的方法 | |
| CA2726691C (en) | Use of oncogene nrf2 for cancer prognosis | |
| JP2016105731A5 (https=) | ||
| JP2021524744A (ja) | 分子遺伝子シグネチャーとその使用方法 | |
| JP2018078911A5 (https=) | ||
| WO2015084808A4 (en) | Identification of predictive biomarkers associated with wnt pathway inhibitors | |
| JP2018506045A5 (https=) | ||
| US20200108066A1 (en) | Methods for modulating regulatory t cells and immune responses using cdk4/6 inhibitors | |
| KR20170094165A (ko) | 화학요법-내성 암을 치료 및 진단하는 조성물 및 방법 | |
| TR201819859T4 (tr) | Akciğer kanseri metastazının tanısı ve prognozu için yöntem. | |
| JP2017523776A (ja) | 膠芽腫の診断方法及びその治療用組成物 | |
| JP2017511131A5 (https=) | ||
| JP2019523641A5 (https=) | ||
| Tian et al. | Expression and prognostic significance of CCL11/CCR3 in glioblastoma | |
| JP2017517507A5 (https=) | ||
| JP2017527533A5 (https=) |